Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study

Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study
复制标题

DOI：
10.1148/radiol.212536
复制
发表时间：
2022-12-01
期刊：
RADIOLOGY
影响因子：
19.7
通讯作者：
Punwani, Shonit
Punwani, Shonit
中科院分区：
医学1区
文献类型：
--
作者：
Singh, Saurabh;Rogers, Harriet;Punwani, Shonit

文献摘要

被引文献

相似文献

背景资料：在怀疑患有前列腺癌（PCa）的男性中，多达50%的多参数MRI（mpMRI）结果阳性（前列腺成像报告和数据系统[PI-RADS]或Likert评分为3或更高）的男性没有临床显著性（Gleason评分
Background: In men suspected of having prostate cancer (PCa), up to 50% of men with positive multiparametric MRI (mpMRI) findings (Prostate Imaging Reporting and Data System [PI-RADS] or Likert score of 3 or higher) have no clinically significant (Gleason score